TELA BIO INC. - COMMON STOCK
3.0100
22-11月-24 16:44:58
15 分の遅延
株式
+0.1200
+4.15%
本日の幅
2.8200 - 3.1000
ISIN
N/A
ソース
NASDAQ
-
TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
25 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
TELA Bio to Participate in Upcoming Investor Conferences
21 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias
19 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Announces First Quarter 2021 Financial Results
13 5 2021 16:02:00 提供 Nasdaq GlobeNewswire
-
TELA Bio to Announce First Quarter 2021 Financial Results
29 4 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
24 3 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair
18 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
02 3 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
04 2 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020
14 1 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio to Participate in Upcoming Needham Virtual Growth Conference
06 1 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development
05 1 2021 07:00:01 提供 Nasdaq GlobeNewswire